Article
Segment 1 - Hepatitis C in the Healthcare Reform Era
Dr Mark Fendrick, University of Michigan, co-editor-in-chief, AJMC, moderates a discussion with Dr David Winston, section head of gastroenterology & hepatology, Cigna HealthCare of Arizona; Dr Steven Miller, chief medical officer, Express Scripts; and Dr Nezam H. Afdhal, associate professor of medicine, Harvard School of Medicine, chief of hepatology, director of Liver Center, Beth Israel Deaconess Medical Center.
Dr Mark Fendrick, University of Michigan, co-editor-in-chief, AJMC, moderates a discussion with Dr David Winston, director, gastroenterology and hepatology, Cigna; Dr Steven Miller, chief medical officer, Express Scripts; and
Dr Nezam H. Afdhal, associate professor of medicine, Harvard School of Medicine, chief of hepatology, director of Liver Center, Beth Israel Deaconess Medical Center.
The group begins to delve into their expertise with hepatology, and discusses the treatment innovations that are emerging in today’s healthcare landscape. They note the growing role of primary care physicians in hepatitis C treatment, and what impact this might have on the healthcare system.
